Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

farmaval peru s.a. - clorhidrato de nafazolina; fosfato de antazolina; - solucion oftalmica - por dosis - nafazolina, combinaciones

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

dermofarm s.a. - nafazolina hidrocloruro; hamamelis agua - colirio en soluciÓn - 0,3 mg/ml + 0,08 ml/ml - nafazolina hidrocloruro 0,3 ml; hamamelis agua 0,08 ml - nafazolina, combinaciones con

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

reva health europe s.l. - nafazolina hidrocloruro; metiltioninio - colirio en soluciÓn - 0,25 mg/ml + 5 microgramos/ml - nafazolina hidrocloruro 0,25 microgramos; metiltioninio 5 microgramos - nafazolina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

faes farma s.a. - nafazolina hidrocloruro - colirio en soluciÓn - 0,2 mg/ml - nafazolina hidrocloruro 0,2 mg - nafazolina - conjuntivitis alérgica

Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

alcon healthcare s.a. - nafazolina hidrocloruro; tetracaina hidrocloruro - colirio en soluciÓn - 0,5 mg/ml + 5 mg/ml - nafazolina hidrocloruro 0,5 mg; tetracaina hidrocloruro 5 mg - combinaciones

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

laboratorios lansier s.a.c. - clorhidrato de nafazolina; - solucion oftalmica - por mililitro ; clorhidrato de nafazolina 0.300000 mg; - nafazolina

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

alcon pharmaceutical del peru s.a. - maleato de feniramina; clorhidrato de nafazolina; - solucion oftalmica - por parche; maleato de feniramina 3.000000 mg; clorhidrato de nafazolina 0.250000 mg; - nafazolina, combinaciones